We included a known covalent MIF inhibitor, 4‐IPP 40 ‐bound MIF structure for a comparison with 1 because 4‐IPP demonstrated higher potency than ISO‐1 against cell migration and anchorage‐independent growth of lung cancer cells without any solvent‐exposing ring structure 40. Here, MIF is linked to lung carcinoma.